Up-Regulation of α 1a and α 1d -Adrenoceptors in the Prostate by Administration of Subtype Selective α 1 -Adrenoceptor Antagonist Tamsulosin in Patients With Benign Prostatic Hyperplasia
Author:
Affiliation:
1. Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya and Taiho Pharmaceutical Co., Ltd. (NO, MK), Hanno Research Center, Hanno Saitama, Japan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference30 articles.
1. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia;Narayan;J Urol,1998
2. Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist;Chapple;Eur Urol,1996
3. Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity;Yokoyama;World J Urol,2010
4. Activation of alpha1D adrenergic receptors in the rat urothelium facilitates the micturition reflex;Ishihama;J Urol,2006
5. Alpha 1-adrenoceptors in human prostate: characterization and binding characteristics of alpha 1-antagonists;Yamada;Life Sci,1994
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Animal models of benign prostatic hyperplasia;Prostate Cancer and Prostatic Diseases;2020-09-01
2. Effects of an alpha-1d adrenoreceptor antagonist (naftopidil) on bladder dysfunction after radiotherapy in female rats;International Urogynecology Journal;2020-08-06
3. Morphological change and characteristics of myofibroblasts during the growth process of benign prostatic hyperplasia;International Journal of Urology;2020-05-31
4. N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis;Scientific Reports;2020-04-29
5. Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia;Scientific Reports;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3